Saturday, October 1, 2022

561.316.3330

Biotechnology News Magazine

BIOTECHNOLOGY

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Neogen Launches New Genomic Management Technology

Neogen notes the Encompass™ platform advances how beef and dairy producers are able to sort and apply genomic data to herd selection and management.

MP Biomedicals Launches New Line of Well-characterized Antibodies, antigens, & ELISA Kits to Advance SARS-CoV-2 Research

MP Biomedicals' extensive line of SARS-CoV-2 research products are fully validated to ensure quality and performance to help advance COVID-19 research.

Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore

Rob Henke, PhD, Vice President of Sales, Asia Pacific, Yourgene Health, said: “By expanding into Singapore’s market, we are able to provide more laboratories access to our technology and, ultimately, offer more patients NIPT as a first call over higher-risk procedures.

CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130™ for the Treatment of Cutaneous T-Cell Lymphomas

“The RMAT designation is an important milestone for the CTX130 program that recognizes the transformative potential of our cell therapy in patients with T-cell lymphomas based upon encouraging clinical data to date,” said Phuong Khanh (P.K.) Morrow, M.D., FACP, Chief Medical Officer of CRISPR Therapeutics. "We continue to work with a sense of urgency to bring our broad portfolio of allogeneic cell therapies to patients in need.”

BioAlberta Recognizes Alberta Innovators and Entrepreneurs at Annual Health and Life Sciences Showcase & Awards Ceremony

“Our life sciences sector is expanding quickly, and the 2022 award recipients showcase Alberta's growing ability to accelerate and develop new technologies that are both sustainable and scalable to produce real-world solutions with a global impact,” said Robb Stoddard, President and CEO of BioAlberta.